openPR Logo
Press release

Oncology Based In-Vivo CRO Market Report : By Size, Trends And Global Forecast 2023-2032 | Crown Bioscience, Toxicon Inc., The Jackson Laboratory, ICON Plc., Wuxi AppTec.

07-12-2023 10:31 AM CET | Health & Medicine

Press release from: The Business research company

Oncology Based In-Vivo CRO Market Trends

Oncology Based In-Vivo CRO Market Trends

The Business Research Company's global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company's Oncology Based In-Vivo CRO Global Market Report 2023 identifies The growing prevalence of cancer is the major driver for the Oncology Based In-Vivo CRO market's growth in the forecast period. With the increasing prevalence of cancer, the demand for innovative treatments and therapies has also increased, driving the growth of the oncology-based in-vivo CRO market. For instance, in 2021, according to the journal published by the American Chemical Society (ACS), a US-based non-profit organization that supports scientific inquiry in the field of chemistry, the global burden of cancer is expected to be 28.4 million cases in 2040, a 47% rise from 2020.

The global oncology-based in-vivo CRO market size is expected to grow from $1.18 billion in 2022 to $1.27 billion in 2023 at a compound annual growth rate (CAGR) of 8.1%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The global oncology-based in-vivo CRO market size is expected to reach $1.79 billion in 2027 at a CAGR of 8.9%.

Download Free Sample Of Oncology Based In-Vivo CRO Market Report
https://www.thebusinessresearchcompany.com/sample.aspx?id=10521&type=smp

Major competitors in the Oncology Based In-Vivo CRO market are Crown Bioscience, Charles River Laboratory International, Toxicon Inc., The Jackson Laboratory, ICON Plc., Wuxi AppTec., Eurofins Scientific Group, Taconic Biosciences Inc., Labcorp Drug Development, Champion Oncology Inc., Xentech Inc., Thermo Fisher Scientific Inc., MI Bioresearch Inc., Clintec International Private Limited, Worldwide Clinical Trials, Pharm-Olam LLC and Clinipace Clinical Research Private Limited.

A key trend in the Oncology Based In-Vivo CRO market includes Product innovations. Major companies operating in the oncology-based in vivo CRO market are focused on developing new solutions to sustain their position in the market. In October 2021, Crown Bioscience, a CRO that provides discovery, preclinical, and translational platforms and services, launched the "3D Ex Vivo Patient Tissue Platform" for improving response predictability to immuno-oncology drug candidates. The platform combines phenotypic three-dimensional models of fresh patient tumors with high-content imaging analysis, providing relevant analysis of drug responses that enables candidate selection and clinical program design.

Read More On The Global Oncology Based In-Vivo CRO Market Report Here:
https://www.thebusinessresearchcompany.com/report/oncology-based-in-vivo-cro-global-market-report

The Oncology Based In-Vivo CRO market is segmented -
By Indication: Blood Cancer, Solid Tumors, Other Indications

By Model: Syngeneic Model, Xenograft, Patient Derived Xenograft (PDX), Other Models

By Application: Hospitals, Rehabilitation Centers

By Geography: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. North America was the largest region in the Oncology Based In-Vivo CRO market.

The Business Research Company's "Global Oncology Based In-Vivo CRO Market Report 2023" provides a thorough understanding of the market across 60 geographies. The report covers market size, growth rate, segments, drivers and trends in every region and country. In addition, the report offers insights on historical and forecast growth, helping players analyze and strategize better.

Explore Buying Options For The Oncology Based In-Vivo CRO Market Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10521

The Table Of Content For The Oncology Based In-Vivo CRO Market Include:
1. Executive Summary
2. Oncology Based In-Vivo CRO Market Characteristics
3. Oncology Based In-Vivo CRO Market Trends And Strategies
4. Oncology Based In-Vivo CRO Market - Macro Economic Scenario
5. Oncology Based In-Vivo CRO Market Size And Growth
……
26. Africa Oncology Based In-Vivo CRO Market
27. Oncology Based In-Vivo CRO Market Competitive Landscape And Company Profiles
28. Key Mergers And Acquisitions In The Oncology Based In-Vivo CRO Market
29. Oncology Based In-Vivo CRO Market Future Outlook and Potential Analysis
30. Appendix

Contact us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Latest Trending Press Releases: https://www.thebusinessresearchcompany.com/press-release.aspx

Want To Know More About The Business Research Company?
The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database
The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Oncology Based In-Vivo CRO Market Report : By Size, Trends And Global Forecast 2023-2032 | Crown Bioscience, Toxicon Inc., The Jackson Laboratory, ICON Plc., Wuxi AppTec. here

News-ID: 3125808 • Views:

More Releases from The Business research company

Customized Premixes Market Share, Opportunities Analysis, Recent Trends, Regional Growth And Outlook By 2033
Customized Premixes Market Share, Opportunities Analysis, Recent Trends, Regiona …
The customized premixes market size has grown strongly in recent years. It will grow from $1.86 billion in 2023 to $2.01 billion in 2024 at a compound annual growth rate (CAGR) of 7.7%. The growth in the historic period can be attributed to increase in health awareness, change in dietary patterns, rise in disposable income, aging population, rise in nutrition deficiencies. The customized premixes market
Custom T-Shirt Printing Market Size, Regional Overview, Competitive Landscape, Business Growth, Share Analysis And Forecast To 2033
Custom T-Shirt Printing Market Size, Regional Overview, Competitive Landscape, B …
The custom t-shirt printing  market size has grown rapidly in recent years. It will grow from $7.46 billion in 2023 to $8.22 billion in 2024 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to customization and personalization trend growth of e-commerce and online printing platforms, increased promotional and marketing activities, increased apparel and fashion industry collaboration, cultural and social
Cryogenic Pump Market Size, Share , Latest Trends, Key Players And Forecast To 2033
Cryogenic Pump Market Size, Share , Latest Trends, Key Players And Forecast To 2 …
The cryogenic pump market size has grown strongly in recent years. It will grow from $2.27 billion in 2023 to $2.42 billion in 2024 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to growth in industrial gas applications (e.g., lng, lpg, liquid nitrogen), expansion of the healthcare and medical gases market, increased demand for cryogenic equipment
Cryogenic Equipment Market Growth Statistics, Regional Analysis, Top Players, Size, And Forecast To 2033
Cryogenic Equipment Market Growth Statistics, Regional Analysis, Top Players, Si …
The cryogenic equipment market size has grown strongly in recent years. It will grow from $14.44 billion in 2023 to $15.85 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth in the historic period can be attributed to increased industrial gas demand, increased need for energy storage and distribution, healthcare and medical applications, space exploration, and energy efficiency. The cryogenic equipment market size is

All 5 Releases


More Releases for CRO

Oncology Based Preclinical CRO Market 2021 | Detailed Report
The Oncology Based Preclinical CRO research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about the
Contract Research Organization (CRO) Market 2021 | Detailed Report
The Contract Research Organization (CRO) research report undoubtedly meets the strategic and specific needs of the businesses and companies. The report acts as a perfect window that provides an explanation of market classification, market definition, applications, market trends, and engagement. The competitive landscape is studied here in terms of product range, strategies, and prospects of the market’s key players. Furthermore, the report offers insightful market data and information about the
Pracedo Promote Ellie Copp To CRO
Pracedo, a Mashfrog Group company that provides Salesforce consultancy and digital transformation to charities, NGOs, and enterprise customers, promotes Ellie Copp to Chief Revenue Officer. Pracedo announced Ellie Copp as its new Chief Revenue Officer (CRO). Ellie joined Pracedo in 2019 and most recently held the position of Sales and Marketing Director. As CRO, she will continue to lead the commercial teams by overseeing all revenue-generating activities as Pracedo continues
Global CRO Services Market Size, Status and Forecast
This report studies the global CRO Services market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global CRO Services market by companies, region, type and end-use industry. Contract research organization (CRO) provide clinical trial and other research support services for the pharmaceutical, biotechnology, medical device industries and also serve government institutions, foundations and universities. Get sample copy of the report: www.marketdensity.com/contact?ref=Sample&reportid=75298 Table of Contents: Table of Contents Global
CRO Services Industry Worldwide Growth and Development
ReportsWeb.com has announced the addition of the “Global CRO Services Market Size, Status and Forecast 2022” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. This report studies the global CRO Services market, analyzes and researches the CRO Services development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the top players in
Partnership factors in sponsor – CRO relationships
Drugs discovered today can realistically cost upwards of 900 million dollars and around 12 years of development to reach a market. CRO’s have been increasingly used by larger pharma to outsource their clinical research, allowing big pharma to shut down in-house R&D, in practice saving money. There have been some issues however with the outsourcing of trials to CROs, including serious relationship break down with negative attitudes, failure to communicate